Circulating cell-free DNA levels are associated with adverse outcomes in heart failure: testing liquid biopsy in heart failure

Authors :: Michele Arcopinto
Eduardo Bossone
Alberto M. Marra
Karen Page
Roberta D'Assante
Shabana Cassambai
Laura Middleton
Giuseppe Rengo
Antonio Cittadini
Jacqueline A Shaw
Muhammad Zubair Israr
Dennis Bernieh
Daniel Fernandez Garcia
Andrea Salzano
Toru Suzuki
Yoshiyuki Yazaki
Salzano, A.
Israr, M. Z.
Garcia, D. F.
Middleton, L.
D'Assante, R.
Marra, A. M.
Arcopinto, M.
Yazaki, Y.
Bernieh, D.
Cassambai, S.
Page, K.
Rengo, G.
Bossone, E.
Cittadini, A.
Shaw, J. A.
Suzuki, T.
Source :: European journal of preventive cardiology. 28(9)
Publication Year :: 2020

Subjects :: Heart Failure
medicine.medical_specialty
Epidemiology
Adverse outcomes
business.industry
MEDLINE
Liquid Biopsy
medicine.disease
Circulating Cell-Free DNA
Internal medicine
Heart failure
medicine
Cardiology
Humans
Liquid biopsy
Cardiology and Cardiovascular Medicine
business
Cell-Free Nucleic Acids

Tools